The blade interacts with TruDi’s artificial intelligence-powered navigation system to alert clinicians when the blade approaches critical anatomical structures, such as the brain or eyes, during surgery.
The tool received FDA clearance for specific procedures and is now available in limited markets, according to a Feb. 23 Acclarent news release.
“We are excited to help pioneer the future of ear, nose and throat with the first patients treated at Mount Sinai using the latest innovation for sinus surgery procedures,” Satish Govindaraj, MD, vice chair of clinical affairs in the department of otolaryngology at Mount Sinai, said in the release. “The straight and angled debrider blades were accurate and efficient. With features like real-time visualization of the blade location, fast anatomical mapping of the powered instruments, and the anatomy segmentation with alerts, we are able to perform an efficient surgery.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
